Relationship between pretreatment concentration of plasma Epstein‐Barr virus DNA and tumor burden in nasopharyngeal carcinoma: An updated interpretation

BACKGROUND: Pretreatment plasma Epstein‐Barr virus (EBV) DNA is an important tumor marker and prognostic factor in nasopharyngeal carcinoma (NPC). This study aimed to clarify the relationship between plasma EBV DNA level and tumor burden. MATERIALS AND METHODS: Pretreatment tumor burden was measured...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Med
Main Authors: Peng, Liang, Yang, Yi, Guo, Rui, Mao, Yan‐Ping, Xu, Cheng, Chen, Yu‐Pei, Sun, Ying, Ma, Jun, Tang, Ling‐Long
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2018
Subjects:
Clinical Cancer Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6308091/
https://ncbi.nlm.nih.gov/pubmed/30378277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1858
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items